Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

ConclusionComorbidities and control of disease activity are critical in the development of CKD in RA patients receiving b/ts-DMARDs. While there was no significant difference in mortality rate between CKD and non-CKD patients, the overall mortality rate increased after the COVID-19 pandemic duration in both groups.

Source: International Journal of Rheumatic Diseases - December 7, 2023 Category: Rheumatology Authors: G üllü Sandal Uzun, Arzu Taghiyeva, İbrahim Y. Çakır, Kenan Moral, Gözde Kübra Yardımcı, Ertuğrul Ç. Bölek, Bayram Farisoğulları, Emine Duran, Gizem Ayan, Zehra Özsoy, Mustafa Ekici, Erdinç Unaldı, Şerife A. Germe, Büşra Tags: ORIGINAL ARTICLE Source Type: research